Dyax drug for rare swelling disease approved for use in younger patients
April 04, 2014 at 14:51 PM EDT
U.S. regulators have approved a drug for an inherited, rare swelling disease called angioedema made by Dyax Corp...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.